Related Experiment Video
Updated: Mar 28, 2026
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression
Benjamin B Shields1, Chad V Pecot2, Hua Gao1
1Departments of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Abstract:
Large-scale molecular annotation of epithelial ovarian cancer (EOC) indicates remarkable heterogeneity in the etiology of that disease. This diversity presents a significant obstacle against intervention target discovery. However, inactivation of miRNA biogenesis is commonly associated with advanced disease. Thus, restoration of miRNA activity may represent a common vulnerability among diverse EOC oncogenotypes. To test this, we employed genome-scale, gain-of-function, miRNA mimic toxicity screens in a large, diverse spectrum of EOC cell lines. We found that all cell lines responded to at least some miRNA mimics, but that the nature of the miRNA mimics provoking a response was highly selective within the panel. These selective toxicity profiles were leveraged to define modes of action and molecular response indicators for miRNA mimics with tumor-suppressive characteristics in vivo. A mechanistic principle emerging from this analysis was sensitivity of EOC to miRNA-mediated release of cell fate specification programs, loss of which may be a prerequisite for development of this disease.
Insights
Restoring microRNA (miRNA) activity shows promise for treating diverse epithelial ovarian cancer (EOC) types. Targeted miRNA mimics selectively kill EOC cells by re-engaging cell fate programs, offering a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Epithelial ovarian cancer (EOC) exhibits significant molecular heterogeneity, complicating targeted therapy development.
- Inactivation of microRNA (miRNA) biogenesis is frequently observed in advanced EOC.
- Restoring miRNA activity could represent a common therapeutic vulnerability across diverse EOC subtypes.
Purpose of the Study:
- To investigate the potential of miRNA restoration as a therapeutic strategy for EOC.
- To identify selective miRNA mimics that induce toxicity in EOC cell lines.
- To elucidate the mechanisms by which miRNA mimics exert anti-cancer effects in EOC.
Main Methods:
- Genome-scale, gain-of-function miRNA mimic toxicity screens were performed across a diverse panel of EOC cell lines.
- Selective toxicity profiles of miRNA mimics were analyzed to determine their modes of action.
- In vivo studies were conducted to assess the tumor-suppressive characteristics of effective miRNA mimics.
Main Results:
- All tested EOC cell lines exhibited sensitivity to at least some miRNA mimics, though responses were highly selective.
- Selective toxicity profiles were successfully leveraged to define miRNA mimic mechanisms and response indicators.
- EOC sensitivity to miRNA-mediated release of cell fate specification programs was identified as a key mechanistic principle.
Conclusions:
- Restoration of miRNA activity is a viable therapeutic approach for epithelial ovarian cancer.
- Targeted miRNA mimics can selectively induce tumor cell death by reactivating cell fate programs.
- Understanding miRNA-mediated cell fate regulation offers new avenues for EOC treatment development.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs